Adam M. Burgoyne, MD, PhD is a board-certified medical oncologist specializing in the diagnosis and treatment of primary liver cancers, as well as cancers of the esophagus, gallbladder, pancreas, stomach, small intestine, colon, and appendix, including gastrointestinal stromal tumors (GIST). Dr. Burgoyne utilizes various therapies, such as chemotherapy, immunotherapy, and targeted therapy, with a focus on personalized medicine, to provide the best possible outcomes for his patients. He is also actively involved in original research to improve survival rates and develop novel drugs for primary liver cancer and other digestive system cancers.
As a member of UC San Diego Health, Dr. Burgoyne leads the multidisciplinary liver cancer clinic, offering specialized and coordinated care in one convenient location. He is dedicated to ensuring easy and timely access to the most innovative treatment approaches and top cancer doctors. With his expertise as a physician-scientist, Dr. Burgoyne's research focuses on tumor genetics, personalized cancer care, and developing targeted therapies. His work has been published in reputable medical journals, including the Journal of Translational Medicine, Molecular Cancer Therapeutics, and Cancer.
Generated from the website